Vijay Singh - Department of nuclear medicine SGPGIMS, India
Shivangi Dixit - Department of nuclear medicine SGPGIMS, India
Manish Ora - Department of nuclear medicine SGPGIMS, India
Aftab Nazar - Department of nuclear medicine SGPGIMS, India

۱۸F-fluorodeoxyglucose Positron emission tomography (۱۸F-FDG PET/CT ) is now being used as a single modality for metastatic workup and response evaluation in breast cancer. An increase in metabolic activity indicates disease progression; however, metabolic flare should be kept in mind. Metabolic flare is a well-documented phenomenon reported in metastatic breast and prostate cancer. Despite a favorable response to therapy, there is a paradoxical increase in radiopharmaceutical uptake. The flare phenomenon with various chemotherapeutic and hormonal agents is well acknowledged in bone scintigraphy. However, very few cases have been documented on PET/CT. Increased uptake may be noted after treatment is instituted. The increased osteoblastic activity is associated with the healing response of bone tumors. We report a case of treated breast cancer. She presented with metastatic recurrence after four years of initial management. The patient was started on paclitaxel chemotherapy. Serial ۱۸F- FDG PET/CT demonstrated metabolic flare and complete metabolic response.

Flare phenomenon, Paclitaxel, Breast Cancer